glp-1 and serotonin plays key role in the development of post-bariatric hypoglycaemia JCI - Postprandial metabolomics analysis
Description
These GLP-1 receptor agonists signal to the brain that you are full, slow down digestion, and help stabilize blood sugar levels
Abstract Aims/hypothesis In humans, glucagon-like peptide-1 (GLP-1) is rapidly degraded by dipeptidyl peptidase-4 to a relatively stable metabolite, GLP-1(936)NH 2 , which allows measurement of GLP-1 secretion
The combined effect of activating both receptors seems to create a synergistic effect, where the benefits are greater than simply adding them together
No, the FDA has not approved GLP-1 patches
[DOI] [PMC free article] [PubMed] [Google Scholar] 70.Wu LL, et al
No insurance is required, all medications come from licensed 503A compounding pharmacies, and coverage is available in all 50 states
